Buparlisib (BKM120) in refractory head and neck squamous cell carcinoma harbouring or not a PI3KCA mutation: A phase II multicenter trial

This article has no abstract
Epistemonikos ID: f7116de2ade6cd410d2a9539765effd7db8ca7d0
First added on: Feb 11, 2025